Generation of reactive oxidant species
Generation of ROS is generally cascade of reactions that starts with the production of O 2
•_ . Superoxide rapidly dismutates to H 2 O 2 either spontaneously, particularly at low pH, or catalyzed by superoxide dismutase (SOD) enzyme. Other steps in the cascade of ROS generation include the reaction of O 2
•_ with ON • to form ONOO -, the peroxidase-catalyzed formation of HOCl from H 2 O 2 , and the iron-catalyzed Fenton reaction leading to the generation of HO •. Hydroxyl radical is one of the most reactive oxygen radicals. In biologic systems, the HO • is formed by the reaction between H 2 O 2 and iron or copper in a low valence state. The oxidized halogens are almost as diverse group of reactive oxidants as are the free radicals. They consist of HOCl and the vast number of chloramines. Chloramines can be produced from the reaction of HOCl with the many amines that are found in biological systems. Like HOCl, the chloramines are oxidizing species. Chloramine (NH 2 Cl) is formed by the reaction of HOCl with ammonia (NH 3 ). The reaction of HOCl with amino acids leads through chloramines to aldehydes. Altogether, the oxidized halogens represent probably the most important microbicidal oxidants produced by neutrophils. Oxygen (O 2 ) alone is a diradical with two unpaired electrons. There is also a much more reactive form of oxygen known as 1 O 2 , in which those two electrons are paired. The 1 O 2 is produced by neutrophils, which manufacture it by the reaction between H 2 O 2 and an oxidized halogen.
Reactive nitrogen species are produced by phagocytes during the reaction of NO with O 2
•_ , and other oxidizing species. The first characterized of these species is ONOO -, formed in a reaction between ON • and O 2
•_ , both of which are free radicals. Peroxynitrite then undergoes a secondary reaction to produce an agent that is able to nitrate tyrosine. The precise composition of the agent is not known, but several candidates have been proposed. Among them are various derivatives of ONOO -. Major cellular sites of ROS generation include the mitochondria, and non-mitochondrial membrane bound enzyme systems (Babior, 2000) .
Reactive oxidant species in the joint tissue
Articular cartilage is a unique tissue for its constituent cells, the chondrocytes, which maintain the cartilage matrix through their continual synthesis and degradation. The environment is avascular, hyperosmotic and acidic. Cartilage cells are synoviocytes, and chondrocytes. Chondrocytes display a metabolism adapted to anaerobic conditions. Synoviocytes supply the avascular cartilage tissue with nutrients via synovial fluid. Because cartilage is an avascular environment, the oxygen tension in the area is usually low. In pathological conditions, like inflammation, oxygen tension is subject of fluctuations. These variations of oxygen tension force chondrocytes to produce reactive species. The main reactive species produced by chondrocytes are O 2
•_ radical, and NO that generate other derivative radicals, including ONOO -and H 2 O 2 (Hiran et al., 1997; Stefanovic-Racic et al., 1997) . The effects of free radicals on articular cartilage are dual. "Chondrocyte-derived" free radical levels are important for the maintenance of ion homeostasis. Natrium hydrogen (Na + -H + ) -exchanger (NHE-activity) and free radical levels exhibit a significant positive correlation. How exactly highly reactive species alter ion transport is not known, although interference with protein phosphorylation is possible (Gibson et al., 2008) .
Except beneficial effect free radicals may have on articular cartilage when exceed in a cell, free radicals damage both chondrocytes, and extracellular matrix (ECM) components of articular cartilage. Free radicals shift the redox balance in articular cartilage in direction of oxidants. Hypochlorous acid, singlet oxygen, and peroxynitrite radicals balance the ascorbate, an antioxidant vitamin, from cartilage (Hajdigogos et al., 2003) .
ROS and RNS damage articular cartilage directly or indirectly by up-regulating the mediators of the ECM degradation. Reactive oxygen/ nitrogen species, e.g. ONOO -, also have been shown to degrade aggrecan, a major component of ECM, and this degradation is one of the initial events in the process of cartilage destruction (Billinghurst et al., 1997) . The incidence of sulfated glycosaminoglycans (GAGs) reflects the ratio of aggrecan degradation in the cartilage.
In seeking for a role of oxidative radicals in cartilage metabolism, it has been noted that endogenously generated NO suppresses the biosynthesis of aggrecan, a major macromolecular component of the cartilaginous matrix (Cao et al., 1997) . Furthermore, it was discovered that oxygen radicals fragment hyaluronan and chondroitin sulphate (Kennett & Davies, 2009 ).
Collagen, which provides tensile strength and forms a network that resists the swelling pressure of aggrecan-hyaluronate aggregates, can be altered directly by oxygen radicals. Free radicals prime collagen to proteolytic enzymes. Incubation of cartilage slices with xanthine-oxidase-generated O 2
•_ anion degrades type I collagen and fibril formation by this collagen. Hydroxyl radical in the presence of oxygen fragments collagen into small peptides. The cleavage seems to be specific to proline or 4-hydroxyproline residues (Monboisse & Borel, 1992) . Interestingly, free radicals may destruct collagen synthesis indirectly. NO inhibits collagen synthesis via interleukin-1 (IL-1) (Cao et al., 1997) . H 2 O 2 inhibits cartilage proteoglycan synthesis interfering with adenosine triphosphate (ATP) synthesis, in part by inhibiting the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase in chondrocytes. ONOO -and HOCl may facilitate cartilage damage by inactivating tissue inhibitor of metalloproteinases (TIMPs). TIMP-1 inhibits stromelysins, collagenases and gelatinases (Henrontin et al., 2003) . Moreover it was observed, that treatment of chondrocytes with the NO-producing agent, S-nitroso-N-acetylpenicillamine, up-regulates the collagenase mRNA levels, which is one of MMPs (Lo et al., 1998) . Exposure of the chondrocytes to H 2 O 2 inhibits proteoglycan synthesis (Henrontin et al., 2003) . Chondrocytes in arthritic cartilage respond poorly to insulin-like growth factor 1 (IGF-1) what may lead to abrogation of cartilage repair. In this context, ROS may participate in reducing the capacity of chondrogenic precursor cells to migrate and proliferate within joint area. Nitric oxide radical was also demonstrated to inhibit chondrocyte migration and attachment to fibronectin via modification of the actin cytoskeleton. Chondrocytes produce high levels of NO, which is a mediator of anti-proliferative effects of IL-1 in these articular cells (Blanco  Lotz, 1994) . In addition, it was discovered that IL-1 induces apoptosis to chondrocytes via NO. Combination of IL-1 with the radical scavengers like N-acetyl cysteine, dimethyl sulfoxide, or 5, 5'-dimetylpyrroline 1-oxide induced apoptosis, which was inhibited in a dose dependent manner by the NO synthase inhibitor N-monomethyl Larginine (Blanco et al., 1995) . Chondrocyte death, determined as the percentage of empty lacunae in articular cartilage, was completely blocked in p47phox-/-mice confirming the "Nicotinamide adenine dinucleotide phosphate" (NADPH)-oxidaseˮ driven oxygen radical production in mediating these effects (Lem van Lent et al., 2005) .
Synoviocytes are the second kind of articular cells. These cells consume larger amount of oxygen when compared to chondrocytes (Schneider et al., 2005 ). An indirect evidence of oxidative stress in synoviocytes is the incidence of antioxidant enzymes such as superoxide dismutase, glutathione peroxidase and catalase in these cells (Mattey et al., 1993) . Oxidative stress makes synoviocytes to undergo a cell death of an apoptotic nature (Galleron et al., 1999) . The ROS scavenger system of synoviocytes protects chondrocytes from toxic effects of free radicals. In a co-culture of these cells synoviocytes reduced toxic effects of H 2 O 2 on chondrocyte cell damage (Kurz et al., 1999) . NO is the primary inducer of apoptosis in human articular chondrocytes (Blanco et al., 1995) . NO -mediated chondrocyte cell death requires generation of additional reactive species like ONOO -and O 2 .
- (Del Carlo Jr. & Loeser, 2002) .
Joint fluid is produced as a transudate of plasma from synovial cells and provides nutrition to the articular cartilage by diffusion of oxygen and other molecules. The primary catalytic antioxidant of the joint fluid is the extracellular SOD (Regan et al., 2008) . SOD type III accounts for 80% of the enzyme's activity in the joint fluid (Afonso et al., 2007) . Glycosaminoglycans (long-chain polysaccharides) are major components of the extracellular matrix, glycocalyx, and synovial fluid. Modifications to these materials are linked to multiple human pathologies including autoimmune diseases. Hyaluronan and chondroitin sulfate are extensively depolymerized by hydroxyl and carbonyl radicals, which may be formed from ONOO -. Polymer fragmentation is shown to be dependent on the radical flux (Kennett & Davies, 2009) . NO, and O 2.-inhibit type II collagen and proteoglycans synthesis and the sulfation of newly synthesized GaGs (Hickery & Bayliss, 1998). 4. Inflammatory synovitis: May oxidative stress be a cause?
ROS in inflammatory synovium
In autoimmune joint diseases systemic inflammation exists long before it exerts local effects on synovial membrane. At one point, systemic inflammation is translocated into synovium where it initiates the inflammatory response often leading to oxidative burst. Oxidative burst in rheumatoid joints is a result of the activation of innate immune system cells. Activated phagocytic cells such as neutrophils, and macrophages both produce free radicals in the joint area. Activated phagocytes produce reactive oxidants by enzymes: the NADPH-oxidase, and the nitric oxide synthase (NOS). Mechanism of free radicals production differs between these cell groups. While macrophages are stimulated by the ˮNADPH-oxidaseˮ system to produce free radicals, the presence of NOS accompanied by the NADPH-oxidase is necessary for neutrophils to secrete free radicals. RA neutrophils also generate enhanced amount of ONOOby NOS (El Benna et al., 2002) . Chemiluminescence assays demonstrated significant activation of the neutrophil myeloperoxidase H 2 O 2 system in synovial fluids from patients with RA further suggesting that oxidative stress may contribute to the cyclic, self-perpetuating nature of rheumatoid inflammation. ROS, produced by activated phagocytes alters the antigenic behaviour of immunoglobulin G (IgG). Radical-exposed IgG is able to bind rheumatoid factor and results in the generation of C3alpha complement component. This reaction may be selfperpetuating within the rheumatoid joint, suggesting that free radicals play a role in the chronicity of rheumatoid inflammation (Newkirk et al., 2002) .
Pro-inflammatory cytokines´ presence and activity undoubtedly subjects to rheumatoid synovitis governing a variety of pathological processes including cell activation, cell proliferation, tissue resorption and chemotaxis (Schett et al., 2000) . Experimental evidence confirms cytokine-induced oxidative stress in rheumatoid synovium. Thioredoxin, a cellular catalyst induced by oxidative stress, is found in high amounts in RA synovial cells and tissue. Thioredoxin acts as a co-factor for tumor necrosis factor-alpha (TNF--induced synthesis of interleukins (IL-6 and IL-8) in synovial fibroblastlike cells (Yoshida et al., 1999) . Edaravone, which is a clinically available antioxidant, suppresses IL-1β-induced synovial cells proliferation and migration under in vitro conditions (Arii et al., 2006) . Nacetylcytein, a known thiol antioxidant, abrogated L-6 -induced proliferation of RA patients synovial fibroblasts (Ji-Yeon et al., 2000) .
ROS are documented as mediators of synovial inflammation. Excessive production of ROS at the site of inflammation contributes to the inflammatory process in general, by induction of the expression of adhesion molecules, pro-inflammatory cytokines, and chemoattractants. Furthermore, ROS can directly increase tissue destruction through inactivation of the major inhibitor of degrading enzymes, 1-antiproteinase, which subsequently leads to the activation of extracellular matrix-degrading metalloproteinases (MMPs) (Maurice et al., 1997) . 3-nitrotyrosine (3-NT) has been identified as a stable end product and marker of inflammation and RNS production. Nitrated proteins are generated in inflamed tissues by inflammatory cells producing ONOO -, a naturally occurring nitrating agent. A study by Khan & Siddiqui (2006) further investigated the binding characteristics of naturally occurring antibodies to 3-NT present in synovial fluid. Antibodies to 3-NT were found higher in the synovial fluid of RA patients.
Ex-vivo cultured rheumatoid synovium produces a significant amount of nitrite, and the addition of N-methylarginine (L-NMMA) significantly inhibits NO production. In vitro study revealed that NO production from freshly isolated synovial cells was up-regulated by stimulation with a combination of IL-1, TNF- and lipopolysaccharide. Inducible NOS expression was induced when human chondrocytes were stimulated with IL-1, TNF- or endotoxin in a dose-and time-dependent manner. Inflammatory reaction in the synovium of RA patients could be augmented by the autocrine or other cytokine-induced production of IL-6 with subsequent generation of ROS in the synoviocytes. Fibroblast-like synoviocytes proliferation by IL-6 was inhibited by N-acetylcysteine. Oxidative stress of RA synovial tissue can cause DNA damage and suppress the DNA mismatch repair (MMR) system in cultured synoviocytes. DNA MMR enzyme expression is greatest in the synovial intimal lining layer, where maximal oxidative stress in RA occurs (Šimelyte et al., 2004) .
Cycles of hypoxia/ reoxygenation in inflammatory synovium
Angiogenesis in the synovial membrane is an important early step in pathogenesis of RA, in the perpetuation of the disease and may precede other pathological features. Elevated levels of pro-angiogenic factor, the vascular endothelial growth factor VEGF, are expressed in synovium, synovial fluids, and serum of RA patients. An increased VEGF level in RA is responsible for subsequent joint destruction. The synovium of RA is hypoxic as a result of synovial tissue proliferation outpacing in angiogenesis. Hypoxia is a potent inducer of cytokines, matrix degrading enzymes, angiogenic factors that play a central role in the inflammatory response. Hypoxia-inducible factor-1 (HIF-1) is a key transcription factor which is highly inducible by hypoxia and expressed predominantly in synovium of RA. Expression of HIF-1 is critical for joint inflammation. RA synovial fluids are hypoxic, acidic with low glucose and elevated lactate concentrations. This biochemical profile is indicative of a chronically hypoxic microenvironment that compensates by anaerobic metabolism. The oxygen partial pressure (pO 2 ) is extremely low in RA synovial fluids, and correlates with elevated plasma levels of lactate. Inflamed synovitis is a hallmark of RA which is hypoxic in nature (Shankar et al., 2009 ). The biological basis of this process relates to hypoxia-inducible factor (HIF). The response of mammalian cells to hypoxia is mediated partly through stabilization of certain transcription factors including HIF-1 and HIF-2. These oxygen sensitive transcription factors are multifunctional. Firstly, they program the cells to anaerobic metabolism, secondly, they enhance cell survival by inhibiting apoptosis, and thirdly they improve the supply of oxygen by promoting angiogenesis and increase oxygencarrying capacity. In view of the crucial role of HIF-1 in cellular adaptation to hypoxia, its regulation needs to be rapidly responsive to changes in the cellular oxygen supply. Inhibition of degradation is the primary mechanism by which hypoxia directly regulates HIF-1. In the absence of oxygen critical step of degradation process of HIF-1, the hydroxylation of proline and asparagine residues, becomes rate limiting, thus preventing HIF-1 from being degraded and leaving it free to bind to its constitutively expressed partner HIF-1β. In rheumatic patients, joint movement in a ratio of normally functional joint increases the pO 2 leading to re-oxygenation. In RA cycling transient episodes of hypoxia/reoxygenation increase levels of ROS. Increased mitochondrial ROS levels stabilize the transcription factor HIF-1 (Chandel et al., 2000) . Of particular relevance to RA was the marked attenuation of synovitis and articular damage in an adjuvant arthritis model when HIF-1 was absent. In RA synovitis, HIF-1a protein accumulates and translocates to the nucleus and directly activates transcription of pro-angiogenic factor like VEGF. VEGF is highly inducible by hypoxia which occurs in the inflamed joints of RA. The HIF-1 translocates and binds to core DNA motif in the hypoxia responsive elements (HRE) which are associated with target genes such as VEGF and induces its gene expression and thereby angiogenesis. HIF-1 is expressed abundantly by macrophages in most rheumatoid synovia, predominantly close to the intimal layer but also in the subintimal zone (Hollander et al., 2001) . The synovial expression of HIF-1 also showed a mixed nuclear and cytoplasmic pattern mostly seen in lining cells, stromal cells, mononuclear cells, and blood vessels (Giatromanolaki et al., 2002) . The number of HIF-1 -positive cells correlated strongly with the number of blood vessels in RA synovial tissue and with inflammatory endothelial cell infiltration (blood vessels), cell proliferation (Ki67) and the synovitis score (Brouwer et al., 2009) . Reduction in the degradation rate of HIFs (HIF-1, and HIF-2) as occurs under hypoxic stress throughout arthritis, results in increased steady-state level of HIFs proteins and up-regulation of the neo-angiogenic process. Neo-angiogenic VEGF/ KDR pathway was shown persistently increased in RA, as indeed was microvessel density and the expression of PD-ECGF, irrespective of the extent of HIF expression (Giatromanolaki et al., 2002) . The direct link exists between accumulation of HIFs and overexpression of VEGF in RA. Neo-angiogenesis contributes to pathogenesis of RA encouraging synovitis, pannus formation and articular cartilage destruction. Concluding, the HIF seems to be a promising factor that targets both synovitis and angiogenesis in RA.
Oxidative stress in human autoimmune joint diseases

Rheumatoid arthritis
Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory disease primarily affecting synovial membranes of joints. Pathogenesis of RA is a multistep process where cellular and humoral interactions mediated by lymphocytes (T and B cells) and non hematopoietic cells like fibroblasts, connective tissue cells, and bone cells play a role. At site of inflammation, activation of T cells and macrophages leads to a large increase in oxygen consumption, whose corollary is increased release of ROS (Afonso et al., 2007) . Both, hematopoietic, and connective tissue cells are subject of oxidative stress process in arthritis.
Hematopoietic cells and tissue as oxidative stress targets in RA
Activity of NADPH-oxidase is enhanced in circulating neutrophils and monocytes of RA patients. These phagocytic cells synthesize two-to eight-fold higher amounts of O 2
•_ when compared to healthy controls. Production rates of O 2
•_ in neutrophils and monocytes from rheumatic patients positively correlate with the plasma levels of TNF- (Miesel et al., 1996) . Other parameters of oxidative stress like decrease in neutrophil SOD activity and an increase in the levels of "loose" iron in the plasmalemma of RA neutrophils and monocytes were also observed (Ostrakhovitch  Afanas´ev, 2001) . A characteristic feature of RA ROSproducing neutrophils is their functional state. The production of O 2
•_ by blood neutrophils from RA patients in response to N-formyl-methionylleucyl-phenylalanine, a stimulatory agent, was greater in arthritic than control blood neutrophils (Eggleton et al., 1995) . The study suggested that stimulated sub-population of neutrophils are source of ROS in arthritis.
Connective cells and tissue as oxidative stress targets in RA
Studies of RA synovial fluid (SF) and tissue have demonstrated oxidative damage to the tissue. Signs of oxidative stress such as DNA oxidative damage, and lipid peroxidation are present in the inflammatory synovium of RA patients. Immunohistochemical analysis revealed increased staining of 8-oxo-7,8-dihydro-2´-deoxyguanine, a marker of DNA oxidative damage, and increased staining of 4-hydroxy-2-nonenal in the lining and sublining layers of the RA inflammatory synovium (Šimelyte et al., 2004) . Furthermore, it was shown that increased lipid peroxidation damage in RA inflammatory synovium is proportional to the levels of hypoxia in the joint, disease activity and angiogenic marker expression (Biniecka et al., 2009) . Synovial fluids macrophages produce increased amounts of O 2
•_ . Also neutrophils from synovial fluids of rheumatic patients generate increased amounts of O 2
•_ possibly because of their exposure to cytokines present in synovial fluids (Hitchon  El-Gabalawy, 2004) . Chronic oxidative stress contributes to functional hyporesponsiveness of synovial T lymphocytes. The impaired mitogenic responses of SF T lymphocytes correlated with a significant decrease in the levels of the intracellular redoxregulating agent glutathione (GSH) (Maurice et al., 1997) .
Indirect evidence for ROS implication in cartilage degradation comes from the presence of lipid peroxidation products, nitrite, nitrotyrosine, a nitrated type II collagen peptide, modified low-density lipoprotein (LDL) and oxidized IgG in the biological fluids of patients with arthritis. Furthermore, nitrotyrosine, nitrated proteins and oxidized LDL (ox-LDL) have been found to be accumulated in cartilage of arthritic patients demonstrating the direct implication of ROS in some joint diseases. Rheumatoid arthritis is characterized by irreversible damage to the cartilage matrix caused by enzymatic degradation of the proteins, e.g., collagen type II (CII), and proteoglycans of cartilage (e.g., aggrecan) (Billinghurst et al., 1997) . As a result of the breakdown of the proteins and proteoglycans, CII degradation products and sulfated glycosaminoglycans (GAGs) appear in SFs of the affected joints. The level of GAGs in SF indicates the extent of proteoglycan degradation (Lark et al., 1997) . Hydrogene peroxide, and singlet oxygen accelerate bone resorption by osteoclasts. Osteoclasts generate ROS through ˮNADPH-oxidase dependent mechanismsˮ. Studies involving assays of nitrotyrosine residues in synovial tissues from patients with RA or exposure of chondrocytes to synthetic peroxynitrite in vitro have established that combination of the O 2 .-anion to nitric oxide (NO) causes cartilage damage (Abramson et al., 2001 ).
The cytokine network is involved in the pathogenesis of RA. IL-1 is a key mediator of bone resorption and cartilage destruction in arthritis. The cytokine activates bone resorption through its effects on osteoclast differentiation and activation. IL-1 destructs cartilage by stimulating release of MMPs from fibroblasts and chondrocytes. Neutralizing ROS activity significantly attenuated IL-1-induced collagenase gene expression in bovine chondrocytes (Lo et al., 1998) .
In RA oxidative stress also features by oxidation of low-density lipoproteins (LDL). Oxidized LDLs promote inflammatory changes including local up-regulation of adhesion molecules and chemokines.
RA tissue has evidence of microsatellite instability reflecting ongoing mutagenesis. Such mutagenesis is normally corrected by DNA repair systems including the mismatch repair system, which is defective in RA, probably due to oxidative stress. 
OXIDATIVE STRESS IN RHEUMATOID ARTHRITIS
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a prototype autoimmune, multisystem and multifactorial disease characterized by the presence of auto-antibodies to a variety of nuclear antigens such as DNA and histones, as well as protein antigens and protein-nucleic acid complexes. The initial immunizing antigen(s) that drive the development of SLE are unknown, but characteristics of the immune response in SLE suggest that it is an antigendriven condition. Multiorgan inflammatory lesions also involve the joints. Immune complex deposits in the synovium are associated with mild inflammation and cartilage destruction is seldom severe. The arthritis of SLE is described as non-destructive and non-deforming. Immune complex deposits in the synovium trigger inflammatory reaction, which led continuously to cartilage destruction (Khan  Siddiqui, 2006) . Free radicals synthesize autoantigens, which contribute to disease development. Oxidative stress and inflammation are interrelated in SLE. Malondialdehyd (MDA) levels positively correlated with levels of interferon- (INF-), and interleukin-12 (IL-12) in lupus disease (Shah et al., 2010) .
Hematopoietic cells and tissue as oxidative stress targets in SLE
Oxidative damage to red blood cells and leukocytes are hallmarks of oxidative stress in SLE. Lipid peroxidation, in SLE erythrocytes, and generation of O 2 .-and H 2 O 2 in leukocytes were increased in SLE patients when compared to healthy controls (Tewthanom et al., 2008) . Destroying effects of free radicals in lupus disease are apparent on the reactions with serum proteins. Oxidation makes the proteins more fragile. Modified proteins become autoantigens, and more, their presence enhances oxidative stress in serum. 4-hydroxy-2-nonenal (4-HNE), which is a marker of lipid peroxidation in SLE, after binding protein forms dangerous protein adducts. The target of 4-HNE modification reported was catalase, a membrane protein of red blood cells (D ' Souza et al., 2008) . Hydroxyl radical binds human serum albumin. The increase in total serum protein carbonyl levels in the SLE patients was largely due to an increase in oxidized albumin (Shjekh et al., 2007) .
In lupus disease, oxidative stress presents by lipid peroxidation mostly. Moreover it was discovered that lipid peroxidation influences pathogenesis of the disease. The disease activity score (SLEDAI) positively correlates with serum levels of MDA. T-lymphocyte apoptosis and MDA were positively associated with disease activity (Shah et al., 2011) . MDA-modified proteins as the catalase, and SOD are targets of IgG circulated autoantibodies promoting disease development. On the other hand, SLEDAI score correlates negatively with serum antioxidant enzymes as SOD, and glutathione peroxidase (GPx) (Taysi et al., 2002 b) . Auto-antibodies against plasma lipoproteins have been reported in SLE patients (Batuca et al., 2007) . The study further documented incidence of antibodies toward high density lipoproteins (HDL) in patients with SLE, and identified Apo A-I as a target of oxidative damage. The incidence of auto-antibodies against lipid particles correlated with reduced activity of paraoxonase (PON), which is the most active antioxidant enzyme in lipids, and also prevents lipid peroxidation of low density lipoproteins (LDL).
Connective cells and tissue as oxidative stress targets in SLE
The arthritis of SLE is described as non-destructive and non-deforming. Immune complex deposits in the synovium are associated with mild inflammation and cartilage destruction is seldom severe. In SLE patients, NO and its intermediates may be mediators of inflammatory arthritis. Antibodies against 3-nitrotyrosine (3-NT) were found elevated in sera, and synovial fluid of SLE patients. Interestingly, the sera levels were much higher than in synovial fluid (Khan & Siddiqui, 2006) .
Markers of oxidative stress in human autoimmune joint diseases
A short lifetime of free radicals in body fluids restricts their direct estimation instead effects of oxygen on lipids, proteins, and nucleic acids molecules are used. There are many chemical modifiers of protein, and lipid structures, whose activity is accelerated by oxidative stress. N-carboxymethyllysine (CML) represents a chemically modified amino acid and originates in vivo from carbohydrate as well as from lipid derived precursors. Oxidative damage to proteins is also reflected by increased levels of advanced oxidation protein products (AOPP), which form by the reaction between chlorinated oxidants (HOCl/OCl _ ) and proteins. AOPP are defined as dityrosine-containing cross-linked proteins. MDA is one of the end products of lipid peroxidation induced by ROS and marker of oxidative stress in lipids. 8-Hydroxy-2´-deoxyguanosine (8-OHdG) has been recognized as a biomarker of oxidative DNA damage by endogenously generated oxygen radicals. In addition, oxidative stress may be estimated by levels of enzymes like thioredoxin, a protein with reduction / oxidation active disulfide / dithiol groups in its active site. Signs of oxidative stress are apparent on cells and tissue affected by arthritis. Advanced glycation end products (AGEs), which are formed during the Maillard reaction by non-enzymatic glycation, and oxidation of proteins were detected in the synovial lining, sublining, and endothelium in RA patiens. CML showed positive immunostaining in some RA macrophages (CD68+) and T cells (CD45RO+) (Drinda et al., 2002) . High levels of protein carbonyl (PCO), and AGE products were found in serum of collagen -induced arthritis mice (Choi, 2007) . Plasma MDA concentrations are significantly higher in RA patients (Sarban et al., 2005 ). An excessive degree of oxidative stress in RA patients confirm decline of protein thiol levels and lower activity of antioxidant enzymes like glutathione (GSH), GPx, and CuZn SOD in blood of these patients (Seven et al., 2008) . The study by Jikimoto (Jikimoto et al., 2001 ) discovered elevated levels of TRX in plasma, and synovial fluid of RA patients. Plasma TRX correlated with urinary excretion of 8-hydroxy-29-deoxyguanosine (8-OHdG). Serum MDA levels were increased in SLE patients, while serum antioxidant levels were decreased in these patients what confirms oxidative stress in the pathology of SLE .
Oxidative stress in autoimmune joint diseases: Beneficial or harmful?
The recent research describes dual role of ROS in autoimmune-joint diseases. The ROS production by the activated NOX-family (NADPH) of oxidases has a principal function throughout the priming phase of the development of autoimmune joint diseases. The NADPH oxidase-deficient knockout mice developed a serious inflammatory arthritis with extensive bone erosions and a massive osteolysis (van de Loo et al., 2003) . ROS might reduce arthritis development influencing circulating inflammatory cells before they reach the joint. ROS limit T cell responses to self-antigens inducing their apoptosis, what inhibits disease development (Olofsson et al., 2003) . Arthritis development correlates with functionality of NADPH-oxidase complex, which is determined by the neutrophil cytosolic factor 1 (Ncf 1), a phagocytic oxidase. The naturally occurring polymorphism of Ncf1 allele limiting the NADPH functionality promotes activation of arthritogenic CD4+ cells. An expansion of arthritogenic T cells owing to the lower activity of the NADPH-oxidase complex was observed in the DA Ncf 1 allele (Olofsson et al., 2003 ). An increased severity of arthritis was observed in animals with either loss of function mutations or deletions in components of the phagocyte NADPH-oxidase like the p47phox (van de Loo et al., 2003) . Furthermore, the effect of NOX-derived ROS might depend on the arthritis model: in IFNgamma (INF-) enhanced imine complex arthritis, the p47phox-deficient animals showed a less severe joint destruction and decreased chondrocyte death (Lem van Lent et al., 2005) .
The NADPH-oxidase-derived superoxide is not exclusive effector molecule in arthritis. Superoxide dismuthase (SOD) catalyses the dismutation of superoxide anion to oxygen and hydrogen peroxide. Three SOD enzyme isoforms have been characterized in humans. SOD I, and SOD III are copper, zinc, enzyme isoforms. SOD II is a manganese enzyme isoform.
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Whereas type I SOD is found mostly in the cytoplasm, nucleus, and intermembrane space of mitochondria, type III of SOD is extracellular. Manganese is cofactor for SOD type II, which is a mitochondrial enzyme. The enzyme is involved in the pathogenesis of inflammatory joint disease. In adjuvant model of arthritis the enzyme suppressed swelling, and retarded bone destruction (Shingu et al., 1994 ). An intra-articular injection of SOD significantly reduced synovitis in streptococcal wall cell (SWC)-model of arthritis. Intra-aricular injection of native SOD (bovine orgotein) produced greater clinical improvements than did intra-articular aspirin in patients with RA involving the knee (Afonso et al., 2007) . Available data suggest a protective role of SOD in inflammatory joint disease. In mice that are genetically deficient in SOD III, both the severity of collagen-induced arthritis and the production of pro-inflammatory cytokines are increased. SODIII gene transferred subcutaneously or intra-articularly decreased the severity of experimental arthritis in rodents.
Antioxidants as therapeutic possibilities in human autoimmune joint diseases
Antioxidant enzymes
SODs exert protective effects in animal models of inflammation. In mice, genetically deficient in SOD III, both the severity of collagen-induced arthritis and the production of pro-inflammatory cytokines are increased (Ross et al., 2004) . SOD III gene transfer into the knee decreased the severity of experimental arthritis in rodents. In humans, serum SOD III levels correlated negatively with disease activity. Despite conflicting results of native SOD (orgotein) in RA patients, SOD mimetics have shown beneficial effects. Until now, the most promising are nitroxide (tempol) and Mn (II) pentaazamacrocyclic ligand (M40403). In vitro, tempol diminishes hydroxyl radical production, and decreases the cytotoxic effects of hydrogen peroxide and peroxynitrite. Tempol decreased collagen-induced arthritis in rats (Cuzzocrea et al., 2001) . The anti-inflammatory effects of M40403 ligand are related to superoxide elimination, and restraint of nitration of tyrosine residues in proteins. M40403 ligand diminishes the expression of adhesion molecules such as integrins or selectins decreasing influx of neutrophils to inflammatory site. M40403 ligand inhibits TNF- via blocking the nuclear factor kappa B (NF-B). Its beneficial effects have been reported in rats with collagen-induced arthritis (Cuzzocrea et al., 2005) .
Vitamins
Micronutrient supplementation has been recommended to arthritic patients based on findings that the antioxidant status is very low in these patients. It has been documented that the mean synovial fluid concentrations of α-tocopherol are significantly decreased in arthritic patients compared to healthy controls. Also, levels of vitamin E in peripheral blood cell were significantly decreased in patients with active arthritis than in healthy subjects . Concentrations of other antioxidant vitamins such as A, C are of lower order in RA and SLE patients than in normal subjects too. Based on animal studies, there is evidence that antioxidant vitamins may prevent arthritis, and increase antioxidant status. Daily oral administration of vitamin E to male arthritic rats restored levels of thiol (-SH) groups to pre-arthritic levels (Kheir-Eldin et al., 1992) . High doses of vitamin C (1-www.intechopen.com 2g/kg body weight) applied to arthritic Lewis rats, delayed incidence of paw oedema in these rats. Histological studies revealed a decreased inflammatory cells infiltration of superficial layer of synovium, and decreased synovial SOD activity in these rats (Sakai et al., 1999) . In addition, administration of rutin (vitamin P) strongly inhibited spontaneous ROS production in RA neutrophils (Ostrakhovitch  Afanas´ev, 2001) . Vitamin E exerts analgetic effects. The results from a double blind clinical trials suggested that a dose of 400-1200 mg of -tocopherol daily was effective with respect to various pain parameters such as pain on pressure, pain at rest, and pain on movement. The postulated analgesic properties of vitamin E seem to be correlated to vitamin E plasma concentrations. Patients with active RA supplemented with a combination of conjugated fatty acids and vitamin E improved their disease activity score. The diet in these patients relieved from night and activity pain, and morning stiffness (Aryaeian et al., 2009 ). The analgesic effect of vitamin E is independent of a peripheral anti-inflammatory action, thereby suggesting a central rather than peripheral action. Dietary antioxidant micronutrients act as scavengers of reactive oxygen radicals and may protect against free radical mediated tissue damage in an inflamed joint. Vitamin E supplemented in soyabean oil reduced anti-double-stranded DNA IgG antibodies (ChiaChien  Bi-Fong, 2005).
Fatty acids
Eicosapentaenoic acid and docosahexaenoic acid (EPA and DHA respectively) exert potent antioxidant properties. Supplementation with these acids to lupus patients restored levels of antioxidant enzymes as the GPx, and SOD to baseline levels (Mohan,  Das, 1997) . Lupus autoimmune female mice fed with fish oil exhibited significantly higher liver of catalase, SOD, and GPx. The diet was shown to be beneficial against oxidative damage of hepatic tissue (Bhattacharya et al., 2003) . Sera of lupus mice treated with conjugated linoleic acid (CLA) contained higher concentrations of total GSH which were negatively correlated with the levels of oxidative stress markers. Moreover, increased GSH, gammaGCL, glutathione Stransferase (GSTs), and NAD(P)H:quinone oxidoreductase (NQO1) activities were measured in liver and spleen of CLA-treated animals. The activation of detoxifying enzymes may be one of the mechanisms whereby dietary CLA down-regulates oxidative stress in lupus mice (Bergamo et al., 2007) .
Conclusions and future perspectives
In all cell types, oxygen metabolism can lead to the production of reactive oxygen / nitrogen species. Reactive species are known for their dual role as both beneficial and harmful. Deleterious effects of oxidative stress on cell components (proteins, lipids, DNA) include changes in their structure, and function. On the other hand, beneficial effects of ROS/RNS involve physiological cellular responses to noxious agents, e.g., in defense against infectious agents, in a number of cellular signaling pathways and in the induction of a mitogenic response. Oxidants even protect cells against oxidative stress and re-establish or maintain redox homeostasis (Ortona et al., 2008) .
Oxygen metabolism has an important role in the pathogenesis of autoimmune joint diseases. Reactive oxygen/nitrogen species are documented as mediators of synovial inflammation. Their excessive production at the site of inflammation contributes to inflammatory process www.intechopen.com
Oxidative Stress and Diseases 450 in general, by induction of local production of chemoattractants, adhesion molecules, and pro-inflammatory cytokines. In addition, oxidative stress may contribute to the cyclic, selfperpetuating nature of autoimmune inflammation. Immune cells when "affected" by oxidants became auto-antigens intensifying auto-immune responses. Persisting autoinflammation, and oxidative stress in joint area leads to damages of connective tissue and the ECM directly or indirectly. In vitro, lipid peroxidation, ONOO -formation is associated with decreased production of type II collagen and aggrecan, and with diminished chondrocyte responses to growth factors. Moreover, ONOO -interferes with metabolism of matrix enhancing the expression of matrix degrading enzymes inhibiting the production and activity of tissue inhibiting enzymes. Hydrogen peroxide and singlet oxygen accelerate bone resorption. Level of oxidative stress in rheumatoid synovium is proportional to the levels of hypoxia and angiogenesis in the joint area.
Oxidative stress generated within an inflammatory joint can produce autoimmune phenomena and connective tissue destruction in rheumatoid synovitis . Swelling stiffness pain in rest immobility are common symptoms of autoimmune joint diseases. Rationale of antioxidant therapy should relieve from objective complications. Polyunsaturated fatty acids (PUFA) can modulate oxidative stress and may have a role as regulators in the synthesis of antioxidant enzymes (Mohan  Das, 1997) . Arthritic patients taking these acids showed biochemical and chemical improvement. Dietary supplementation significantly decreased joint pain index. In combination with other dietary modifications modest improvement in morning stiffness and in the number of painful joints were reported. Clinical improvements were connected with anti-inflammatory effects as a decreased synthesis of leukotriens by neutrophils and lower synthesis of IL-1 by macrophages. Significant clinical benefit has been claimed in SLE patients given a low-fat diet with PUFA (reviewed in Darlington  Stone, 2001) . The clinical work with diets containing PUFA has clearly demonstrated their anti-inflammatory effects, but it was also shown that these effects were attributed to omega-3 (-3) rather than -6 PUFA. As there is no doubt about dietary fatty acids do decrease the generation of inflammatory agents, opposite results have been obtained on free radical formation. PUFA are especially potent at increasing levels of oxidative stress. On the other hand, EPA increases mitochondrial Mn-SOD mitochondrial activity.
The hypothesis about oxidative stress promotes arthritic process was challenged when oxidants were shown to decrease disease severity in mouse and rat arthritis models. Certain oils with an alkane structure such as phytol besides its oxidative effects protect against arthritis development. Its subcutaneous administration prevented development of pristaneinduced arthritis (Hultqvist et al., 2006) . Rats treated with phytol in acute phases of pristane arthritis showed no signs of inflammation. A decrease in COMP, a measurement of ongoing cartilage destruction, was prevented during chronic phases of the disease. The efficiency of phytol in preventing arthritis was compared to methotrexate and/or etanecerpt. Etanecerpt, TNF- blocker, was highly effective in reducing collagen-induced arthritis. In pristaneinduced arthritis, the preventive effects of phytol was more pronounced than that of etanecerpt. Also, in comparison to MTX, phytol was valid as a potential therapeutic agent. Concluded, ROS-promoting substances such as phytol represent a promising class of therapeutics for treatment of autoimmune joint inflammatory diseases what needs further research.
www.intechopen.com 
Acknowledgements
The work was supported by VZ 0021620816 and by 262708/SVV/2011 and by CN LC 554.
